Disialoganglioside GD2 in human neuroectodermal tumor cell lines and gliomas
- 1 June 1991
- journal article
- research article
- Published by Springer Nature in Acta Neuropathologica
- Vol. 82 (1) , 45-54
- https://doi.org/10.1007/bf00310922
Abstract
Monoclonal antibodies (mAbs) recognizing the disialoganglioside II3(NeuAc)2GgOse3Cer (GD2) were produced by immunizing mice with the GD2-expressing neuroblastoma cell line LAN-1 and a prefusion boost with purified GD2 coupled to Salmonella minnesota. Two IgM mAbs were isolated which demonstrated high levels of reactivity (binding ratios in excess of 100) with GD2 by solid-phase radioimmunoassay and positivity in high-performance thin-layer chromatography (HPTLC) immunostain; only one (DMAb-20) was subsequently shown by analysis with a panel of defined ganglioside species to be specific for the minimum epitope of GD2, GalNAcβ1-4(NeuAcα2-8NeuAcα2-3)Gal-. DMAb-20 was used to evaluate the expression of GD2 by malignant glioma and medulloblastoma cell lines using cell surface radioimmunoassay, indirect membrane immunofluorescence, HPTLC immunostain, and densitometric analysis of extracted gangliosides from selected cell lines. Sixteen of 20 (80%) malignant glioma and 5 of 5 medulloblastoma cell lines reacted with DMAb-20; in agreement with previous studies, 5 of 5 neuroblastoma and 2 of 3 melanoma cell lines also reacted with DMAb-20. GD2 was proportionally increased in the glioma and medulloblastoma cell lines relative to levels in normal brain, as determined by densitometric analysis. In a phenotypic survey of malignant glioma biopsies, tumor cells in 24 of 30 (80%) cases stained positively with DMAb-20. Reactive astrocytes, both within and adjacent to tumors, were frequently intensely stained. Among the morphological variants of glioblastoma examined, the most intense staining with DMAb-20 was observed in neoplastic gemistocytes, with the weakest or absent staining in small cell glioblastomas. As GD2 is a commonly expressed surface antigen of gliomas and medulloblastomas, expression of which is retained in tissue culture, DMAb-20 will be useful in determining the functional role of GD2 in cell-cell interaction, adhesion, and invasion, and in defining altered growth control mechanisms of central nervous system neoplasms in in vitro models.Keywords
This publication has 44 references indexed in Scilit:
- Gangliosides in the human glioma cell line U-118 MG grown in culture or as xenografts in nude ratsBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1990
- Mouse monoclonal antibodies detecting disialogangliosides on mouse and human t lymphomasInternational Journal of Cancer, 1988
- Gangliosides of human spinal cord: Aberrant composition of cords from patients with amyotrophic lateral sclerosisJournal of Neuroscience Research, 1984
- Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures.Journal of Histochemistry & Cytochemistry, 1981
- A procedure for the quantitative isolation of brain gangliosidesBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1980
- The Nomenclature of LipidsEuropean Journal of Biochemistry, 1977
- LIPID COMPOSITION OF HUMAN GLIAL TUMOUR AND ADJACENT BRAIN*Journal of Neurochemistry, 1967
- THE PATTERN OF MAMMALIAN BRAIN GANGLIOSIDES—IIIJournal of Neurochemistry, 1965
- CHROMATOGRAPHlC SEPARATION OF HUMAN BRAIN GANGLIOSIDES*Journal of Neurochemistry, 1963
- Quantitive estimation of sialic acidsBiochimica et Biophysica Acta, 1957